Yuki Yamada

No ORCID on file · 23 papers in corpus · active 2006-2024

Study types

  • article 15
  • review 5
  • other 3

Condition tags

  • endometriosis 17
  • endometrioma 11
  • mesh:D004715 9
  • adenomyosis 1
  • dysmenorrhea 1
  • mesh:D004412 1
  • chronic_pelvic_pain 1
  • mesh:D017699 1
other 2024
Diagnostics ·doi:10.3390/diagnostics14111069

BACKGROUND: Endometriosis-associated ovarian cancer (EAOC) is a well-known type of cancer that arises from ovarian endometrioma (OE). OE contains iron-rich fluid in its cysts due to repeated hemorrhages in the ovaries. However, distinguishi…

review 2023
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.15456

Obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) is a rare malformation that not only causes severe menstrual cramps shortly after menarche but can also lead to endometriosis and infection in the future. We report a case of OHVI…

article 2022
Diagnostics ·doi:10.3390/diagnostics12051212

This study aimed to evaluate the prediction efficacy of malignant transformation of ovarian endometrioma (OE) using the Copenhagen Index (CPH-I), the risk of ovarian malignancy algorithm (ROMA), and the R2 predictive index. This retrospecti…

article 2022
Biomedicines ·doi:10.3390/biomedicines10112683

Background: Magnetic resonance (MR) relaxometry provides a noninvasive tool to discriminate endometriosis-associated ovarian cancer (EAOC) from ovarian endometrioma (OE) with high accuracy. However, this method has a limitation in discrimin…

article 2021
Archives of medical research ·doi:10.1016/j.arcmed.2021.03.006
article 2021
Redox report : communications in free radical research ·doi:10.1080/13510002.2021.1937456

OBJECTIVES: Magnetic resonance (MR) R2 relaxometry is a safe, noninvasive diagnostic modality for the evaluation of iron levels in the contents of ovarian cysts. The study aims to investigate the sensitivity and specificity of the two metho…

other 2021
International journal of clinical oncology ·doi:10.1007/s10147-021-01914-y

BACKGROUND: Tissue factor pathway inhibitor 2 (TFPI2) is a novel serum biomarker that discriminates ovarian clear cell carcinoma (CCC) from borderline ovarian tumors (BOTs) and non-clear cell epithelial ovarian cancers (EOCs). Here, we exam…

article 2019
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.14093

AIM: Expression of CD44 variant isoforms (CD44v) promotes the synthesis of reduced glutathione and contributes to reactive oxygen species defense through up-regulation of the intracellular antioxidant. The aim of the study was to investigat…

other 2019
Journal of ovarian research ·doi:10.1186/s13048-019-0497-1

BACKGROUND: Common cancerous histological types associated with endometriosis are clear cell carcinoma (CCC) and endometrioid carcinoma (EC). CCC is regarded as an aggressive, chemoresistant histological subtype. Magnetic resonance imaging …

article 2019
Scientific reports ·doi:10.1038/s41598-019-54096-z

We aimed to retrospectively analyze the risk factors of a continuous dienogest (DNG) therapy for serious unpredictable bleeding in patients with symptomatic adenomyosis. This is a retrospective study based on data extracted from medical rec…

article 2018
Pathology, research and practice ·doi:10.1016/j.prp.2018.12.017
article 2018
Oncology letters ·doi:10.3892/ol.2018.9242

The present study aimed to evaluate the levels of oxidative stress and antioxidant markers in benign endometrioma (OE) and its malignant transformation [endometriosis‑associated ovarian cancer (EAOC)] by measuring 8‑hydroxy‑2‑deoxyguanosine…

article 2018
Experimental and therapeutic medicine ·doi:10.3892/etm.2018.5779

The aim of the present single-center retrospective study was to investigate the discrimination of malignant transformation from ovarian endometrioma (OE) using a near‑infrared approach ex vivo. Cystic fluid samples were collected from patie…

review 2018
Oncology reports ·doi:10.3892/or.2018.6946

In the present study, we summarize the role of the shared and independent (epi)genetic background between endometrioid carcinoma (EC) and clear cell carcinoma (CCC), two histological subtypes of endometriosis-associated ovarian cancer (EAOC…

article 2018
Oncology letters ·doi:10.3892/ol.2018.9721

Endometriosis-associated ovarian cancer (EAOC) is a rare entity and has highly variable morphological presentations. Mural nodules can be seen in EAOC and benign ovarian endometrioma (OE), which causes a diagnostic dilemma. The differential…

article 2017
article 2017
review 2017
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719117704909

Aberrant DNA methylation and histone modification are associated with an increased risk of reproductive disorders such as endometriosis. However, a cause-effect relationship between epigenetic mechanisms and endometriosis development has no…

review 2014
Human immunology ·doi:10.1016/j.humimm.2013.12.012

Comparison of the transcriptomes and proteomes of the decidualization-specific genes that express high vs low levels of the eutopic and ectopic endometrium of women with endometriosis compared with controls, could be useful in understanding…

article 2014
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719114526473
review 2014
Archives of gynecology and obstetrics ·doi:10.1007/s00404-013-3049-8

PURPOSE: Endometriosis-associated pelvic pain appears due to persistent nociceptive stimulation, but the precise mechanisms remain poorly understood. METHODS: A search was conducted to screen and select articles from PubMed. MAIN RESULTS:…

article 2010
·doi:10.1016/j.jmig.2010.08.490
article 2006
·doi:10.1136/ijgc-00009577-200607000-00008